217 related articles for article (PubMed ID: 34503188)
1. Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis.
Russo GI; Sholklapper TN; Cocci A; Broggi G; Caltabiano R; Smith AB; Lotan Y; Morgia G; Kamat AM; Witjes JA; Daneshmand S; Desai MM; Gill IS; Cacciamani GE
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503188
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
Chen C; Huang H; Zhao Y; Liu H; Sylvester R; Lin T; Huang J
BMJ Open; 2019 Oct; 9(10):e028173. PubMed ID: 31628123
[TBL] [Abstract][Full Text] [Related]
3. Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer.
Lai LY; Tafuri SM; Ginier EC; Herrel LA; Dahm P; Maisch P; Lane GI
Cochrane Database Syst Rev; 2022 Apr; 4():CD014887. PubMed ID: 35393644
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer.
Chen C; Huang H; Zhao Y; Liu H; Luo Y; Sylvester RJ; Li JP; Lam TB; Lin T; Huang J
J Cancer; 2020; 11(5):1082-1093. PubMed ID: 31956355
[No Abstract] [Full Text] [Related]
5. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
[TBL] [Abstract][Full Text] [Related]
6. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.
Lee JY; Cho KS; Kang DH; Jung HD; Kwon JK; Oh CK; Ham WS; Choi YD
BMC Cancer; 2015 Aug; 15():566. PubMed ID: 26232037
[TBL] [Abstract][Full Text] [Related]
7. Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials.
Sari Motlagh R; Mori K; Laukhtina E; Aydh A; Katayama S; Grossmann NC; Mostafai H; Pradere B; Quhal F; Schuettfort VM; Roshandel MR; Karakiewicz PI; Teoh J; Shariat SF; Fajkovic H
BJU Int; 2021 Sep; 128(3):280-289. PubMed ID: 33683778
[TBL] [Abstract][Full Text] [Related]
8. Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.
Mulawkar PM; Sharma G; Tamhankar A; Shah U; Raheem R
Front Surg; 2022; 9():762027. PubMed ID: 35265660
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
Soorojebally Y; Neuzillet Y; Lebret T; Allory Y; Descotes F; Ferlicot S; Kassab-Chahmi D; Lamy PJ; Oudard S; Rébillard X; Roy C; Roumiguié M; Rouprêt M; Audenet F
Prog Urol; 2023 May; 33(6):307-318. PubMed ID: 37088584
[TBL] [Abstract][Full Text] [Related]
10. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
11. Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: a prospective comparison to the standard approach.
Geavlete B; Jecu M; Multescu R; Geavlete P
Ther Adv Urol; 2012 Oct; 4(5):211-7. PubMed ID: 23024703
[TBL] [Abstract][Full Text] [Related]
12. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic effects of fluorescence cystoscopy and narrow-band imaging in bladder cancer: a systematic review and network meta-analysis.
Fan Z; Shi H; Luo J; Guo X; Wang B; Liu Y; Yu J
Int J Surg; 2023 Oct; 109(10):3169-3177. PubMed ID: 37526087
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.
Mowatt G; Zhu S; Kilonzo M; Boachie C; Fraser C; Griffiths TR; N'Dow J; Nabi G; Cook J; Vale L
Health Technol Assess; 2010 Jan; 14(4):1-331, iii-iv. PubMed ID: 20082749
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
[TBL] [Abstract][Full Text] [Related]
16. Hexaminolevulinate in the Management of Nonmuscle Invasive Bladder Cancer: A Meta-Analysis.
Konecki T; Kutwin P; Łowicki R; Juszczak AB; Jabłonowski Z
Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):551-558. PubMed ID: 31339825
[No Abstract] [Full Text] [Related]
17. A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.
Lapini A; Minervini A; Masala A; Schips L; Pycha A; Cindolo L; Giannella R; Martini T; Vittori G; Zani D; Bellomo F; Cosciani Cunico S
Surg Endosc; 2012 Dec; 26(12):3634-41. PubMed ID: 22729704
[TBL] [Abstract][Full Text] [Related]
18. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy.
Kim SB; Yoon SG; Tae J; Kim JY; Shim JS; Kang SG; Cheon J; Lee JG; Kim JJ; Kang SH
Investig Clin Urol; 2018 Mar; 59(2):98-105. PubMed ID: 29520385
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis.
Mowatt G; N'Dow J; Vale L; Nabi G; Boachie C; Cook JA; Fraser C; Griffiths TR;
Int J Technol Assess Health Care; 2011 Jan; 27(1):3-10. PubMed ID: 21262078
[TBL] [Abstract][Full Text] [Related]
20. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
Daneshmand S; Bazargani ST; Bivalacqua TJ; Holzbeierlein JM; Willard B; Taylor JM; Liao JC; Pohar K; Tierney J; Konety B;
Urol Oncol; 2018 Aug; 36(8):361.e1-361.e6. PubMed ID: 29859728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
